Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MVD | P53602 | 2/20 | 0.39 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29050786 | 1.00 | MVD (0.39) | MVDNOS3NOS1NOS2CA1 | |
| SCHEMBL15514032 | 0.98 | MVD (0.40) | MVDNOS3NOS1NOS2CA1 | |
| SCHEMBL28000874 | 0.98 | MVD (0.40) | MVDNOS3NOS1NOS2CA1 | |
| Water SCHEMBL28582154 | 0.95 | MVD (0.40) | MVDNOS3NOS1NOS2CA1 | |
| SCHEMBL1739489 | 0.95 | MVD (0.42) | MVDNOS3NOS1NOS2CA1 | |
| SCHEMBL29007316 | 0.88 | NOS3 (0.37) | MVDNOS3NOS1NOS2CA1 | |
| SCHEMBL4110528 | 0.86 | NOS3 (0.38) | MVDNOS3NOS1NOS2CA1 | |
| SCHEMBL1065568 | 0.84 | CA4 (0.39) | MVDNOS3NOS1NOS2CA1 | |
| SCHEMBL27714199 | 0.84 | CA4 (0.39) | MVDNOS3NOS1NOS2CA1 | |
| SCHEMBL27962723 | 0.84 | CA4 (0.39) | MVDNOS3NOS1NOS2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2276494-B1 | STABLE AQUEOUS COMPOSITIONS COMPRISING BIOACTIVE CREATINE SPECIES | OWOC JOHN H (US) | 2015-10-21 | — | — | EP | disclosed |
| US-9114150-B2 | Stable aqueous compositions comprising bioactive creatine species | JHO INTELLECTUAL PROPERTY HOLDINGS, LLC (US) | 2015-08-25 | — | — | US | disclosed |
| US-20130143842-A1 | STABLE AQUEOUS COMPOSITIONS COMPRISING BIOACTIVE CREATINE SPECIES | ENERGY BEVERAGES LLC | 2013-06-06 | — | — | US | disclosed |
| US-8372821-B2 | Stable aqueous compositions comprising bioactive creatine species | ENERGY BEVERAGES LLC | 2013-02-12 | — | — | US | disclosed |
| EP-2276494-A1 | STABLE AQUEOUS COMPOSITIONS COMPRISING BIOACTIVE CREATINE SPECIES | Owoc, John H. (US) | 2011-01-26 | — | — | EP | disclosed |
| WO-2009126174-A1 | STABLE AQUEOUS COMPOSITIONS COMPRISING BIOACTIVE CREATINE SPECIES | OWOC JOHN H (US) | 2009-10-15 | — | — | WO | disclosed |
| US-20090257997-A1 | Stable Aqueous Compositions Comprising Bioactive Creatine Species | ENERGY BEVERAGES LLC | 2009-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130143842-A1 | STABLE AQUEOUS COMPOSITIONS COMPRISING BIOACTIVE CREATINE SPECIES | CKMT1A; CKMT1B, REN, PYGM | MVD 3214/4885NOS3 1568/4885NOS1 1779/4885 |
| US-20090257997-A1 | Stable Aqueous Compositions Comprising Bioactive Creatine Species | CKMT1A; CKMT1B, REN, PYGM | MVD 3405/4885NOS3 1291/4885NOS1 1539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.